MR1 Protein (AA 201-300) (GST tag)

Catalog No. ABIN1311253

Product Details

Target: MR1 (Major Histocompatibility Complex, Class I-Related (MR1))

Protein Type: Recombinant

Protein Characteristics: AA 201-300

Origin: Human

Source: Wheat germ

Purification tag / Conjugate: This MR1 protein is labelled with GST tag.

Application: ELISA, Affinity Purification (AP), Antibody Array (AA), Western Blotting (WB)

Purpose: MR1 (Human) Recombinant Protein (Q01)

Sequence: TEPPLVRVNR KETFPGVTAL FCKAHGFYPP EIYMTWMKNG EEIVQEIDYG DILPSGDGTY QAWASIELDP QSSNLYSCHV EHCGVHMVLQ VPQESETIPL

Characteristics: Human MR1 partial ORF ( NP_001522, 201 a.a. - 300 a.a.) recombinant protein with GST-tag at N-terminal.

Purification: in vitro wheat germ expression system

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Comment:

Preparation method: in vitro, wheat germ expression system
Product Quality tested by: 12.5% SDS-PAGE Stained with Coomassie Blue.

Restrictions: For Research Use only

Handling

Buffer: 50 mM Tris-HCI, 10 mM reduced Glutathione, pH =8.0 in the elution buffer.

Handling Advice: Aliquot to avoid repeated freezing and thawing.

Storage: -80 °C

Storage Comment: Best use within three months from the date of receipt of this protein.

Target Details

Target: MR1 (Major Histocompatibility Complex, Class I-Related (MR1))

Alternative Name: MR1 (MR1 Products)

Synonyms: YFV Protein, hlals Protein, MGC154362 Protein, MR1 Protein, DKFZp468C1823 Protein, HLALS Protein, H2ls Protein, Hlals Protein, MHC class I antigen YF5 Protein, major histocompatibility complex, class I-related Protein, major histocompatibility complex, class I-related L homeolog Protein, YF5 Protein, MR1 Protein, mr1.L Protein, mr1 Protein, Mr1 Protein

Background: Full Gene Name: major histocompatibility complex, class I-related
Synonyms: HLALS

Gene ID: 3140

NCBI Accession: NM_001531

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints